Skip to main content
. 2018 Jan 23;2018:3295605. doi: 10.1155/2018/3295605

Figure 2.

Figure 2

The results of synergy susceptibility testing. (a) Synergy susceptibility testing represented synergism between imipenem and ceftazidime (red square). CR-Kp was resistant to imipenem (blue square). (b) No synergism between imipenem and clavulanic acid (yellow square). CR-Kp was resistant to imipenem (blue square). CAZ, ceftazidime; IPM, imipenem; CLA, clavulanic acid.